Omnicell, Inc. (NASDAQ:OMCL) Shares Bought by Connors Investor Services Inc.

Connors Investor Services Inc. increased its position in Omnicell, Inc. (NASDAQ:OMCL) by 64.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,547 shares of the company’s stock after buying an additional 37,502 shares during the period. Connors Investor Services Inc. owned about 0.21% of Omnicell worth $2,793,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of OMCL. Vanguard Group Inc. raised its holdings in Omnicell by 15.1% in the 3rd quarter. Vanguard Group Inc. now owns 5,137,084 shares of the company’s stock valued at $231,374,000 after acquiring an additional 674,824 shares during the last quarter. Diversified Trust Co increased its stake in Omnicell by 10.2% in the fourth quarter. Diversified Trust Co now owns 12,544 shares of the company’s stock valued at $472,000 after purchasing an additional 1,162 shares during the last quarter. Raymond James & Associates lifted its position in Omnicell by 3.6% during the fourth quarter. Raymond James & Associates now owns 94,907 shares of the company’s stock worth $3,571,000 after buying an additional 3,254 shares during the period. Pacer Advisors Inc. boosted its stake in Omnicell by 321,488.8% in the 4th quarter. Pacer Advisors Inc. now owns 1,058,027 shares of the company’s stock worth $39,814,000 after buying an additional 1,057,698 shares during the last quarter. Finally, Assenagon Asset Management S.A. purchased a new stake in Omnicell in the 4th quarter valued at about $13,687,000. Hedge funds and other institutional investors own 97.70% of the company’s stock.

Omnicell Price Performance

OMCL stock remained flat at $27.52 during midday trading on Friday. 368,496 shares of the company’s stock were exchanged, compared to its average volume of 584,583. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.38 and a quick ratio of 2.13. Omnicell, Inc. has a 1 year low of $25.12 and a 1 year high of $66.65. The stock’s fifty day simple moving average is $28.87 and its 200-day simple moving average is $29.27. The company has a market cap of $1.26 billion, a P/E ratio of -59.83, a P/E/G ratio of 97.59 and a beta of 0.80.

Omnicell (NASDAQ:OMCL) last announced its quarterly earnings results on Thursday, May 2nd. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.17. Omnicell had a negative net margin of 1.91% and a positive return on equity of 2.41%. The firm had revenue of $246.15 million during the quarter, compared to analysts’ expectations of $235.70 million. As a group, research analysts forecast that Omnicell, Inc. will post 0.2 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

OMCL has been the topic of several research analyst reports. StockNews.com cut shares of Omnicell from a “buy” rating to a “hold” rating in a research report on Tuesday, July 16th. Benchmark reissued a “buy” rating and set a $38.00 price objective on shares of Omnicell in a research note on Monday, July 15th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Omnicell presently has a consensus rating of “Hold” and a consensus target price of $42.20.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.